BackImmix Biopharma Overview

Immix Biopharma Current Cash

Track Immix Biopharma's current cash ($230M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$225.49M
↑ 1837.56% YoYΔ $213.85M vs prior year quarter

Peer trimmed avg / median

Loading

Immix Biopharma Current Cash History

Loading

Immix Biopharma vs. peers: Current Cash Comparison

Loading

Immix Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

As of the most recent data (June 2026), IMMX shows a current cash of $230M. That compares with $12M in the prior-year period — up 1837.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMMX's current cash is now $230M (was $12M) — a 1837.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immix Biopharma is outperforming or lagging.

Tracking IMMX's current cash over time shows whether Immix Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $12M in the prior-year period — up 1837.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Immix Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $230M) with ownership activity and broader fundamentals.